NEU 3.50% $14.05 neuren pharmaceuticals limited

Ann: Phase 3 enrolment successfully completed, results in Q4 2021, page-87

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,168 Posts.
    lightbulb Created with Sketch. 572
    Hi Prodigy,

    $4-5 IF successful from phase 3, was more a reference point of if there is a positive announcement of success we initially would move to this figure off the back of such a announcement. Conservative figure given our trading point today with recent CR and all.

    Agree if successful from phase 3 Trof more value will be added to share price in due coarse more likely along the lines as you have referenced as revenue is forcast and cash is brought in for ROW deals and a like, dives in Trof will also help confidence in no-2591 all helping bolster the share price beyond $4-5

    Given our current position and lack of interest from the market it is hard to see $10-20, whilst I would welcome this valuation from successful phase 3 Trof think we will need more progress and positive signs from NZ-2591 in phase 2 for this.

    The reality is our MC is a joke after 10 years, given our stage today, fully funded phase 3 Trof US deal, retaining
    ROW rights results due this quarter??? Cashed up for NZ-2591 ready for phase 2 in 4-5 indications, resting all global rights.

    I am just hanging on also, but staggering at the lack of interest this close to results.

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$14.05
Change
-0.510(3.50%)
Mkt cap ! $1.795B
Open High Low Value Volume
$14.38 $14.42 $13.94 $6.419M 454.6K

Buyers (Bids)

No. Vol. Price($)
1 500 $13.99
 

Sellers (Offers)

Price($) Vol. No.
$14.07 6644 4
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.